Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?.
Research article published in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2002)
Abstract
We report on the treatment failure of low molecular weight heparin (LMWH) for anticoagulation in a pregnant woman that underwent artificial mitral valve replacement 10 years prior to her pregnancy. Until she became pregnant warfarin was administered for anticoagulation, but due to the often mentioned increased risk for warfarin-induced maternal and fetal complications, at gestational week 5 the anticoagulation regimen was switched to subcutaneous application of low molecular weight heparin. At gestational week 24 our patient developed acute life-threatening pulmonary edema and hemodynamic instability due to acute mitral valve thrombosis and underwent emergency valve re-replacement with a biological porcine valve. She recovered uneventfully and gave birth to a healthy child at gestational week 35. In addition to our case presentation we review the sparse evidence in the literature regarding anticoagulation in pregnant women with mechanical heart valves and discuss the rational of different anticoagulation regimens with regards to maternal and fetal outcome. Special consideration is directed towards LMWH administration as an alternative to oral anticoagulation during pregnancy in women with mechanical heart valves.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?.
Warum dies für die Hirudotherapie relevant ist
Dieser Fallbericht beschreibt ein Therapieversagen von niedermolekularem Heparin zur Antikoagulation bei einer Schwangeren mit mechanischer Mitralklappenprothese, die in der Schwangerschaftswoche 24 eine akute Klappenthrombose entwickelte, die einen notfallmäßigen Klappenersatz erforderlich machte, und gibt einen Überblick über Antikoagulationsoptionen für Schwangere mit mechanischen Herzklappen. Die Zusammenfassung enthält keine Erwähnung von Blutegeln, Hirudin oder jeglicher von Blutegeln abgeleiteten Therapie. Daher weist dieser Artikel keine vertretbare Relevanz für Hirudotherapie oder das Blutegelsekretom auf.
Zitation
Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?.
Leyh et al. · European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2002
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026